Key result
Peritoneal dialysis was associated with a higher rate of renal function recovery compared to hemodialysis in patients with malignant hypertension.
Why the study?
Does peritoneal dialysis improve recovery of renal function compared to hemodialysis in Black South African patients with malignant hypertension and end-stage renal failure?
Cohort (n=31)
Yes
Does peritoneal dialysis improve recovery of renal function compared to hemodialysis in Black South African patients with malignant hypertension and end-stage renal failure?
Peritoneal dialysis may be superior to hemodialysis for promoting the recovery of renal function in patients with end-stage renal failure caused by malignant hypertension.
Answers are grounded in this paper and cite their sources.
Supports peritoneal dialysis consideration in malignant hypertension; leaves open confirmation in randomized trials.
OBJECTIVE: To describe recovery of renal function (RC) in Black South African patients with primary malignant hypertension (MHT) and end-stage renal failure, according to the type of dialysis provided. DESIGN: A retrospective analysis of the records of 31 patients with MHT. SETTING: A university-based, large tertiary-care hospital and its community-based satellite continuous ambulatory peritoneal dialysis (CAPD) clinics. PATIENTS: Only patients with renal failure caused by MHT and who were on dialysis between January 1997 and June 2000. There were 11 patients on peritoneal dialysis (PD) that regained renal function; 11 patients on hemodialysis (HD), none of whom recovered renal function; and 9 patients on PD who did not recover renal function during the same time period. OUTCOME MEASURES: The groups were investigated for variables that might predict RC. RESULTS: Peritoneal dialysis compared with HD was highly significant as an indicator of RC (p < 0.0001), with 60% of patients on PD regaining renal function, versus 0% on HD. Median time to recovery was 300 (150 -365) days. There was no significant difference in decline of mean arterial pressure (MAP) between the groups; MAP declined significantly in all groups (p = 0.00002). All groups received similar drug therapy. In the RC group, initial MAP, kidney size, and urine output tended to be higher and creatinine lower (p = not significant). Dialysis adequacy was similar in the different groups. CONCLUSIONS: This retrospective study suggests there may be benefit from PD as the primary form of dialysis when patients have MHT as a cause of their renal failure. Possible predictors of RC include blood pressure control, initial MAP, initial serum creatinine, initial urine output, and kidney size. Time should be allowed for RC before transplantation is undertaken. Prospective studies are needed to confirm the benefit of CAPD in patients with MHT.
No takes yet. Share an insight, caveat, or question.
Katz et al. (2001) conducted a cohort in Primary malignant hypertension and end-stage renal failure (n=31). Peritoneal dialysis vs. Hemodialysis was evaluated on Recovery of renal function (p=< 0.0001). Peritoneal dialysis was associated with a higher rate of renal function recovery compared to hemodialysis in patients with malignant hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: